Chris Wagner of Emerald Health on the impact of the Canadian Marijuana Industry at a Global Scale

At the CanTech Investment Conference in Toronto, the Investing News Network had the opportunity to speak with Chris Wagner, CEO of Emerald Health Therapeutics about how Canada’s framework for legalization of marijuana will be impactful on a global scale, the company’s joint venture with DMG Blockchain, and how Emerald Health will meet with the rising demand of cannabis once legalization in Canada is fully in effect.


%d bloggers like this: